Glycolysis and pyruvate oxidation in cardiac hypertrophy--why so unbalanced?

H S Leong1, R W Brownsey, J E Kulpa

  • 1McDonald Research Laboratories/The iCAPTUR4E Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6.

Insights

Cardiac hypertrophy alters heart energy metabolism, uncoupling glucose use and production. Impaired pyruvate dehydrogenase complex (PDC) function is not the sole cause, suggesting other metabolic pathways are involved.

Area of Science:

  • Biochemistry
  • Cardiology
  • Metabolic research

Background:

  • Cardiac hypertrophy involves abnormal heart energy metabolism and structural changes.
  • Increased glycolysis and glucose utilization occur, but pyruvate oxidation doesn't match pyruvate production.
  • This leads to uncoupled glycolysis and glucose oxidation in hypertrophied hearts.

Purpose of the Study:

  • To test the hypothesis that pyruvate dehydrogenase complex (PDC) function is impaired in cardiac hypertrophy.
  • To investigate the mechanisms behind altered pyruvate metabolism in hypertrophied hearts.

Main Methods:

  • Review of existing evidence on cardiac hypertrophy and glucose metabolism.
  • Analysis of the role of pyruvate dehydrogenase complex (PDC) in controlling glucose oxidation.
  • Discussion of potential alternative mechanisms affecting pyruvate metabolism.

Main Results:

  • Alterations in glucose metabolism in cardiac hypertrophy are not solely explained by changes in PDC expression or control.
  • Evidence suggests that altered pyruvate metabolism involves more than just PDC function.

Conclusions:

  • The uncoupling of glycolysis and glucose oxidation in cardiac hypertrophy is complex.
  • Additional factors, including pyruvate transport, NADH shuttles, lactate dehydrogenase, and amino acid metabolism, may contribute to altered pyruvate metabolism.

Related Concept Videos

What is Glycolysis?00:56

What is Glycolysis?

Overview
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Fates of Pyruvate01:20

Fates of Pyruvate

Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Glycolysis01:23

Glycolysis

Glycolysis, the Embden-Meyerhof pathway, is a central metabolic pathway involved in glucose catabolism. It is highly conserved across most organisms, reflecting its fundamental role in cellular energy production. This process occurs in the cytoplasm and can function both in the presence and absence of oxygen, making it versatile for various organisms and environmental conditions.Stages of GlycolysisGlycolysis is a ten-step pathway that converts glucose into pyruvate, generating a net gain of...